Clinical characteristics of VTE and ATE
| . | n (%) . |
|---|---|
| VTE (47 events) | |
| Type | |
| DVT | 17 (36.2) |
| PE | 18 (38.3) |
| DVT + PE | 3 (6.4) |
| Splanchnic vein thrombosis | 5 (10.6) |
| Catheter-related thrombosis | 4 (8.5) |
| Symptoms | |
| Symptomatic | 19 (40.4) |
| Incidental | 22 (46.8) |
| No information regarding symptoms available | 4 (8.5) |
| Fatal* | 2 (4.3) |
| ATE (9 events) | |
| Type | |
| STEMI | 2 (22.2) |
| NSTEMI | 2 (22.2) |
| Ischemic stroke | 3 (33.3) |
| Acute vascular occlusion | 2 (22.2) |
| Symptoms | |
| Symptomatic | 7 (77.8) |
| No information regarding symptoms available | 1 (11.1) |
| Fatal | 1 (11.1) |
| . | n (%) . |
|---|---|
| VTE (47 events) | |
| Type | |
| DVT | 17 (36.2) |
| PE | 18 (38.3) |
| DVT + PE | 3 (6.4) |
| Splanchnic vein thrombosis | 5 (10.6) |
| Catheter-related thrombosis | 4 (8.5) |
| Symptoms | |
| Symptomatic | 19 (40.4) |
| Incidental | 22 (46.8) |
| No information regarding symptoms available | 4 (8.5) |
| Fatal* | 2 (4.3) |
| ATE (9 events) | |
| Type | |
| STEMI | 2 (22.2) |
| NSTEMI | 2 (22.2) |
| Ischemic stroke | 3 (33.3) |
| Acute vascular occlusion | 2 (22.2) |
| Symptoms | |
| Symptomatic | 7 (77.8) |
| No information regarding symptoms available | 1 (11.1) |
| Fatal | 1 (11.1) |
AP, angina pectoris; CRT, catheter-related thrombosis; CVA, cerebral vascular attack (ischemic stroke); NSTEMI, non-ST-elevation myocardial infarction; STEMI, ST-elevation myocardial infarction.
Includes 1 patient who died under the clinical suspicion of PE, and PE could not be ruled out as a cause of death.